Bright Minds Biosciences Inc. (DRUG:NASDAQ) jumped higher at $4.17, a gain of 29.5%. On Tue, Aug 08, 2023, DRUG:NASDAQ touched a New 2-Week High of $4.17. The stock appeared on our News Catalysts scanner on Tue, Aug 08, 2023 at 07:35 AM in the 'BIOTECH' category. From Tue, Jul 25, 2023, the stock recorded 50.00% Up Days and 36.36% Green Days
The stock spiked on Tue, Aug 08, 2023 at $6.44 with a volume of 30M+.
About Bright Minds Biosciences Inc. (DRUG:NASDAQ)
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain.
Top 10 Gainers:
- Bruush Oral Care Inc. (BRSH:NASDAQ), 139.13%
- Vivos Therapeutics Inc. (VVOS:NASDAQ), 53.22%
- Infinity Pharmaceuticals, Inc. (INFI:NASDAQ), 45.88%
- IronNet Inc. (IRNT:NYSE), 41.67%
- Cardiff Oncology Inc. (CRDF:NASDAQ), 38.85%
- Tilray, Inc. (TLRY:NASDAQ), 36.04%
- Signature Bank (SBNY:NASDAQ), 33.33%
- VeriFone Systems, Inc. (PAY:NYSE), 31.22%
- Bright Minds Biosciences Inc. (DRUG:NASDAQ), 29.5%
- Fresh2 Group Ltd Sponsored ADR (New) (FRES:NASDAQ), 29.41%